Pages with the fewest revisions

Showing below up to 500 results in range #1 to #500.

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)

1. ICRP Publication 25‏‎ (1 revision)
2. Relative biological effectiveness‏‎ (1 revision)
3. ICRP Publication 31‏‎ (1 revision)
4. Deterministic effect‏‎ (1 revision)
5. ICRP Publication 98‏‎ (1 revision)
6. ICRP Publication 46‏‎ (1 revision)
7. ICRP Publication 60‏‎ (1 revision)
8. Dose modifying factor‏‎ (1 revision)
9. Somatic effect‏‎ (1 revision)
10. ICRP Publication 75‏‎ (1 revision)
11. ICRP Publication 9‏‎ (1 revision)
12. Targeted effects‏‎ (1 revision)
13. 1934 Recommendations‏‎ (1 revision)
14. Access control‏‎ (1 revision)
15. Typical value‏‎ (1 revision)
16. General Information: Radon‏‎ (1 revision - redirect page)
17. Particle transport‏‎ (1 revision)
18. ICRP Publication 108‏‎ (1 revision)
19. Brachytherapy‏‎ (1 revision)
20. ICRP Publication 121‏‎ (1 revision)
21. Case–control study‏‎ (1 revision)
22. ICRP Publication 136‏‎ (1 revision)
23. Collective dose‏‎ (1 revision)
24. ICRP Publication 150‏‎ (1 revision)
25. Reference Person‏‎ (1 revision)
26. ICRP Publication 26‏‎ (1 revision)
27. DS86‏‎ (1 revision)
28. Relative life lost‏‎ (1 revision)
29. ICRP Publication 32‏‎ (1 revision)
30. ICRP Publication 99‏‎ (1 revision)
31. ICRP Publication 47‏‎ (1 revision)
32. Security screening‏‎ (1 revision)
33. ICRP Publication 61‏‎ (1 revision)
34. ICRP Publication 76‏‎ (1 revision)
35. Stochastic effect‏‎ (1 revision)
36. Equilibrium equivalent concentration‏‎ (1 revision)
37. Expanded radiation field‏‎ (1 revision)
38. 1937 Recommendations‏‎ (1 revision)
39. Tolerance dose‏‎ (1 revision)
40. Adventitious source‏‎ (1 revision)
41. Occupancy factor‏‎ (1 revision)
42. Annual intake‏‎ (1 revision)
43. ICRP Publication 109‏‎ (1 revision)
44. ICRP Publication 122‏‎ (1 revision)
45. ICRP Publication 137‏‎ (1 revision)
46. Radon-prone area‏‎ (1 revision)
47. ICRP Publication 151‏‎ (1 revision)
48. ICRP Publication 27‏‎ (1 revision)
49. Relative risk‏‎ (1 revision)
50. ICRP Publication 33‏‎ (1 revision)
51. Detriment-adjusted risk‏‎ (1 revision)
52. Ring chromosome‏‎ (1 revision)
53. ICRP Supporting Guidance 2‏‎ (1 revision)
54. ICRP Publication 48‏‎ (1 revision)
55. Dose-response function‏‎ (1 revision)
56. ICRP Publication 62‏‎ (1 revision)
57. International Commission on Radiological Protection‏‎ (1 revision)
58. ICRP Publication 77‏‎ (1 revision)
59. Lag‏‎ (1 revision)
60. Equilibrium factor‏‎ (1 revision)
61. Teratocarcinoma‏‎ (1 revision)
62. Low dose‏‎ (1 revision)
63. 1950 Recommendations‏‎ (1 revision)
64. Backscatter factor‏‎ (1 revision)
65. Potentially lethal damage repair‏‎ (1 revision)
66. ICRP Publication 10A‏‎ (1 revision)
67. ICRP Publication 123‏‎ (1 revision)
68. Charged-particle equilibrium‏‎ (1 revision)
69. ICRP Publication 138‏‎ (1 revision)
70. Collimation‏‎ (1 revision)
71. ICRP Publication 152‏‎ (1 revision)
72. ICRP Publication 28‏‎ (1 revision)
73. Relative survival‏‎ (1 revision)
74. ICRP Publication 34‏‎ (1 revision)
75. ICRP Publication 49‏‎ (1 revision)
76. ICRP Publication 63‏‎ (1 revision)
77. Source region‏‎ (1 revision)
78. ICRP Publication 78‏‎ (1 revision)
79. Elemental dose‏‎ (1 revision)
80. Late normal tissue responses‏‎ (1 revision)
81. Exposed individuals‏‎ (1 revision)
82. 1954 Recommendations‏‎ (1 revision)
83. Α/β value‏‎ (1 revision)
84. Oncogene‏‎ (1 revision)
85. Apoptosis‏‎ (1 revision)
86. ICRP Publication 11‏‎ (1 revision)
87. ICRP Publication 124‏‎ (1 revision)
88. ICRP Publication 139‏‎ (1 revision)
89. ICRP Publication 153‏‎ (1 revision)
90. ICRP Publication 29‏‎ (1 revision)
91. ICRP Publication 35‏‎ (1 revision)
92. ICRP Publication 5‏‎ (1 revision)
93. Dose-threshold hypothesis‏‎ (1 revision)
94. Severe deterministic injury‏‎ (1 revision)
95. ICRP Publication 64‏‎ (1 revision)
96. Intervention‏‎ (1 revision)
97. ICRP Publication 79‏‎ (1 revision)
98. Sublethal damage repair‏‎ (1 revision)
99. 1956 Recommendations‏‎ (1 revision)
100. Transfer of risk‏‎ (1 revision)
101. Molecular imaging‏‎ (1 revision)
102. Activation‏‎ (1 revision)
103. Noise‏‎ (1 revision)
104. ΓH2AX foci‏‎ (1 revision)
105. Operating management‏‎ (1 revision)
106. Pencil beam‏‎ (1 revision)
107. ICRP Publication 1‏‎ (1 revision)
108. Baseline disease rates‏‎ (1 revision)
109. Practice‏‎ (1 revision)
110. ICRP Publication 110‏‎ (1 revision)
111. Breakpoint cluster region/abelson‏‎ (1 revision)
112. ICRP Publication 125‏‎ (1 revision)
113. ICRP Publication 14‏‎ (1 revision)
114. Commissioning‏‎ (1 revision)
115. ICRP Publication 154‏‎ (1 revision)
116. Cosmic radiation‏‎ (1 revision)
117. ICRP Publication 3‏‎ (1 revision)
118. ICRP Publication 36‏‎ (1 revision)
119. Dicentric chromosome‏‎ (1 revision)
120. Risk model‏‎ (1 revision)
121. ICRP Publication 50‏‎ (1 revision)
122. Dose and dose-rate effectiveness factor‏‎ (1 revision)
123. Sheltering‏‎ (1 revision)
124. Induced genomic instability‏‎ (1 revision)
125. ICRP Publication 65‏‎ (1 revision)
126. ICRP Publication 8‏‎ (1 revision)
127. Licensee‏‎ (1 revision)
128. Thermodynamic diameter‏‎ (1 revision)
129. Low linear energy transfer radiation‏‎ (1 revision)
130. 1959 Decisions‏‎ (1 revision)
131. Nominal risk coefficient‏‎ (1 revision)
132. Hereditary effect‏‎ (1 revision)
133. ICRP Publication 10‏‎ (1 revision)
134. ICRP Publication 111‏‎ (1 revision)
135. Quality control testing‏‎ (1 revision)
136. ICRP Publication 126‏‎ (1 revision)
137. Radioactive waste‏‎ (1 revision)
138. ICRP Publication 140‏‎ (1 revision)
139. ICRP Publication 155‏‎ (1 revision)
140. ICRP Publication 30‏‎ (1 revision)
141. Dental and maxillofacial imaging‏‎ (1 revision)
142. ICRP Publication 37‏‎ (1 revision)
143. ICRPædia Guide to Radiological Protection in Healthcare‏‎ (1 revision - redirect page)
144. ICRP Publication 51‏‎ (1 revision)
145. Shielding‏‎ (1 revision)
146. ICRP Publication 66‏‎ (1 revision)
147. ICRP Publication 80‏‎ (1 revision)
148. Superposition principle‏‎ (1 revision)
149. Life Span Study‏‎ (1 revision)
150. Thoracic airways‏‎ (1 revision)
151. Multifactorial diseases‏‎ (1 revision)
152. Active detection system‏‎ (1 revision)
153. Nominal value‏‎ (1 revision)
154. ICRP Publication 100‏‎ (1 revision)
155. ICRP Publication 112‏‎ (1 revision)
156. ICRP Publication 127‏‎ (1 revision)
157. ICRP Publication 141‏‎ (1 revision)
158. ICRP Publication 16‏‎ (1 revision)
159. Reference parameter value‏‎ (1 revision)
160. ICRP Publication 30 (Index)‏‎ (1 revision)
161. ICRP Publication 38‏‎ (1 revision)
162. ICRP Publication 52‏‎ (1 revision)
163. Dose commitment‏‎ (1 revision)
164. ICRP Publication 67‏‎ (1 revision)
165. Doubling dose‏‎ (1 revision)
166. ICRP Publication 81‏‎ (1 revision)
167. Supervised area‏‎ (1 revision)
168. Evacuation‏‎ (1 revision)
169. Thoron progeny‏‎ (1 revision)
170. Exposure index‏‎ (1 revision)
171. AML/eto‏‎ (1 revision)
172. Transgenerational effect‏‎ (1 revision)
173. Frequent flyer‏‎ (1 revision)
174. Non-homologous end joining‏‎ (1 revision)
175. Optimisation of protection‏‎ (1 revision)
176. Attributable risk‏‎ (1 revision)
177. ICRP Publication 101‏‎ (1 revision)
178. Best available techniques‏‎ (1 revision)
179. ICRP Publication 113‏‎ (1 revision)
180. Bronchiolar region‏‎ (1 revision)
181. Quasi-threshold dose‏‎ (1 revision)
182. ICRP Publication 128‏‎ (1 revision)
183. ICRP Publication 142‏‎ (1 revision)
184. Compartment‏‎ (1 revision)
185. Radon progeny‏‎ (1 revision)
186. ICRP Publication 17‏‎ (1 revision)
187. Count median diameter‏‎ (1 revision)
188. Reference phantom‏‎ (1 revision)
189. ICRP Publication 30 (Part 1)‏‎ (1 revision)
190. Deposition‏‎ (1 revision)
191. ICRP Publication 90‏‎ (1 revision)
192. ICRP Publication 39‏‎ (1 revision)
193. Digital breast tomosynthesis‏‎ (1 revision)
194. ICRP Publication 53‏‎ (1 revision)
195. Size-specific dose estimate‏‎ (1 revision)
196. ICRP Publication 68‏‎ (1 revision)
197. Specific absorbed fraction‏‎ (1 revision)
198. ICRP Publication 82‏‎ (1 revision)
199. Surface contamination‏‎ (1 revision)
200. Excess absolute risk‏‎ (1 revision)
201. Exposure pathway‏‎ (1 revision)
202. Translocation‏‎ (1 revision)
203. Multistage carcinogenesis model‏‎ (1 revision)
204. Functional subunits‏‎ (1 revision)
205. Activity median aerodynamic diameter‏‎ (1 revision)
206. Ground-level enhancement‏‎ (1 revision)
207. Phantom‏‎ (1 revision)
208. ICRP Publication 101a‏‎ (1 revision)
209. ICRP Publication 114‏‎ (1 revision)
210. ICRP Publication 129‏‎ (1 revision)
211. ICRP Publication 143‏‎ (1 revision)
212. Compartment (environmental)‏‎ (1 revision)
213. Ras‏‎ (1 revision)
214. ICRP Publication 18‏‎ (1 revision)
215. Cross section‏‎ (1 revision)
216. Reference value‏‎ (1 revision)
217. ICRP Publication 30 (Part 2)‏‎ (1 revision)
218. ICRP Publication 91‏‎ (1 revision)
219. ICRP Publication 4‏‎ (1 revision)
220. ICRP Publication 54‏‎ (1 revision)
221. Slice‏‎ (1 revision)
222. ICRP Publication 69‏‎ (1 revision)
223. ICRP Publication 83‏‎ (1 revision)
224. Threshold level‏‎ (1 revision)
225. Organ at risk‏‎ (1 revision)
226. Homologous recombination‏‎ (1 revision)
227. Authorised discharge‏‎ (1 revision)
228. ICRP Publication 101b‏‎ (1 revision)
229. Principles of protection‏‎ (1 revision)
230. ICRP Publication 115‏‎ (1 revision)
231. Radiation-induced second cancer‏‎ (1 revision)
232. ICRP Publication 13‏‎ (1 revision)
233. Clinical audit‏‎ (1 revision)
234. ICRP Publication 144‏‎ (1 revision)
235. Rb‏‎ (1 revision)
236. ICRP Publication 19‏‎ (1 revision)
237. Reference worker‏‎ (1 revision)
238. ICRP Publication 30 (Part 3)‏‎ (1 revision)
239. Derived consideration reference level‏‎ (1 revision)
240. ICRP Publication 92‏‎ (1 revision)
241. ICRP Publication 40‏‎ (1 revision)
242. ICRP Publication 55‏‎ (1 revision)
243. Dose conversion convention‏‎ (1 revision)
244. Informed consent‏‎ (1 revision)
245. ICRP Publication 7‏‎ (1 revision)
246. Spongiosa‏‎ (1 revision)
247. ICRP Publication 84‏‎ (1 revision)
248. Exclusion‏‎ (1 revision)
249. Marrow cellularity‏‎ (1 revision)
250. Multitarget equation‏‎ (1 revision)
251. Acute exposure‏‎ (1 revision)
252. Allometry‏‎ (1 revision)
253. Pilomatricoma‏‎ (1 revision)
254. ICRP Publication 102‏‎ (1 revision)
255. ICRP Publication 116‏‎ (1 revision)
256. Radiation-induced secondary malignancy‏‎ (1 revision)
257. ICRP Publication 130‏‎ (1 revision)
258. Radiological attack‏‎ (1 revision)
259. ICRP Publication 145‏‎ (1 revision)
260. Reactive oxygen species‏‎ (1 revision)
261. ICRP Publication 2‏‎ (1 revision)
262. Referrer‏‎ (1 revision)
263. ICRP Publication 30 (Part 4)‏‎ (1 revision)
264. Derived investigation level‏‎ (1 revision)
265. ICRP Publication 93‏‎ (1 revision)
266. ICRP Publication 41‏‎ (1 revision)
267. Directional dose equivalent‏‎ (1 revision)
268. ICRU 4-element tissue‏‎ (1 revision)
269. ICRP Publication 56‏‎ (1 revision)
270. Dose conversion factor‏‎ (1 revision)
271. ICRP Publication 70‏‎ (1 revision)
272. Effect modifier‏‎ (1 revision)
273. ICRP Publication 85‏‎ (1 revision)
274. Endosteum‏‎ (1 revision)
275. System of radiological protection‏‎ (1 revision)
276. Time-resolved computed tomography‏‎ (1 revision)
277. Mutation component‏‎ (1 revision)
278. Waste management‏‎ (1 revision)
279. Normal tissue complication probability‏‎ (1 revision)
280. Biological half-life‏‎ (1 revision)
281. ICRP Publication 117‏‎ (1 revision)
282. ICRP Publication 131‏‎ (1 revision)
283. Radiological controlled area‏‎ (1 revision)
284. ICRP Publication 146‏‎ (1 revision)
285. Concentration ratio‏‎ (1 revision)
286. ICRP Publication 20‏‎ (1 revision)
287. ICRP Publication 21‏‎ (1 revision)
288. Region‏‎ (1 revision)
289. ICRP Publication 30 (Supplement A to Part 3)‏‎ (1 revision)
290. Derived limit‏‎ (1 revision)
291. ICRP Publication 94‏‎ (1 revision)
292. ICRP Publication 42‏‎ (1 revision)
293. ICRU sphere‏‎ (1 revision)
294. ICRP Publication 57‏‎ (1 revision)
295. ICRP Publication 71‏‎ (1 revision)
296. ICRP Publication 86‏‎ (1 revision)
297. Treatment preparation in radiotherapy‏‎ (1 revision)
298. Notification value‏‎ (1 revision)
299. Other (systemic) tissues‏‎ (1 revision)
300. Human Alimentary Tract Model‏‎ (1 revision)
301. ICRP Publication 104‏‎ (1 revision)
302. Biomarker‏‎ (1 revision)
303. ICRP Publication 132‏‎ (1 revision)
304. Clonogenic surviving fraction‏‎ (1 revision)
305. ICRP Publication 147‏‎ (1 revision)
306. Cone beam computed tomography‏‎ (1 revision)
307. ICRP Publication 22‏‎ (1 revision)
308. Regional diagnostic reference levels‏‎ (1 revision)
309. ICRP Publication 30 (Supplement B to Part 3)‏‎ (1 revision)
310. Derived reference level‏‎ (1 revision)
311. ICRP Publication 95‏‎ (1 revision)
312. ICRP Publication 43‏‎ (1 revision)
313. Disposal facility‏‎ (1 revision)
314. Sealed source‏‎ (1 revision)
315. ICRP Publication 58‏‎ (1 revision)
316. Solar flare‏‎ (1 revision)
317. ICRP Publication 72‏‎ (1 revision)
318. ICRP Publication 87‏‎ (1 revision)
319. Linear dose response‏‎ (1 revision)
320. Mean glandular dose‏‎ (1 revision)
321. Absorption Type‏‎ (1 revision - redirect page)
322. Trophic level‏‎ (1 revision)
323. Additional dose‏‎ (1 revision)
324. Nuclear medicine‏‎ (1 revision)
325. Ambient dose equivalent‏‎ (1 revision)
326. Human Respiratory Tract Model‏‎ (1 revision)
327. Automatic exposure control‏‎ (1 revision)
328. Pooled analysis‏‎ (1 revision)
329. ICRP Publication 105‏‎ (1 revision)
330. ICRP Publication 119‏‎ (1 revision)
331. Radiation risk‏‎ (1 revision)
332. ICRP Publication 133‏‎ (1 revision)
333. ICRP Publication 148‏‎ (1 revision)
334. ICRP Publication 23‏‎ (1 revision)
335. DRL quantity‏‎ (1 revision)
336. Registry‏‎ (1 revision)
337. ICRP Publication 30 (Supplement to Part 1)‏‎ (1 revision)
338. Designated area‏‎ (1 revision)
339. ICRP Publication 96‏‎ (1 revision)
340. ICRP Publication 44‏‎ (1 revision)
341. Distribution coefficient‏‎ (1 revision)
342. Secondary radiation‏‎ (1 revision)
343. ICRP Publication 59‏‎ (1 revision)
344. Intake‏‎ (1 revision)
345. ICRP Publication 73‏‎ (1 revision)
346. Standard-size adult‏‎ (1 revision)
347. ICRP Publication 88‏‎ (1 revision)
348. Epigenetic effects‏‎ (1 revision)
349. 1928 Recommendations‏‎ (1 revision)
350. Tissue reaction‏‎ (1 revision)
351. Measured quantity‏‎ (1 revision)
352. Tumour suppressor gene‏‎ (1 revision)
353. National DRL‏‎ (1 revision)
354. Additive risk projection model‏‎ (1 revision)
355. Oxygen enhancement ratio‏‎ (1 revision)
356. Population risk‏‎ (1 revision)
357. ICRP Publication 106‏‎ (1 revision)
358. ICRP Publication 12‏‎ (1 revision)
359. ICRP Publication 134‏‎ (1 revision)
360. Cobblestone area forming cell assay‏‎ (1 revision)
361. ICRP Publication 149‏‎ (1 revision)
362. Redox‏‎ (1 revision)
363. ICRP Publication 24‏‎ (1 revision)
364. ICRP Publication 30 (Supplement to Part 2)‏‎ (1 revision)
365. Detector quantum efficiency‏‎ (1 revision)
366. ICRP Publication 97‏‎ (1 revision)
367. ICRP Publication 45‏‎ (1 revision)
368. Secretory cells‏‎ (1 revision)
369. ICRP Publication 6‏‎ (1 revision)
370. Intensity-modulated radiotherapy‏‎ (1 revision)
371. ICRP Publication 74‏‎ (1 revision)
372. Stem cell‏‎ (1 revision)
373. Kerma approximation‏‎ (1 revision)
374. ICRP Publication 89‏‎ (1 revision)
375. Exogenous excretion‏‎ (1 revision)
376. 1931 Recommendations‏‎ (1 revision)
377. National radon survey‏‎ (1 revision)
378. Adenoma‏‎ (1 revision)
379. Potential alpha energy concentration‏‎ (1 revision)
380. ICRP Publication 107‏‎ (1 revision)
381. ICRP Publication 120‏‎ (1 revision)
382. Carers and comforters‏‎ (1 revision)
383. ICRP Publication 135‏‎ (1 revision)
384. ICRP Publication 15‏‎ (1 revision)
385. Rigidity‏‎ (2 revisions)
386. Dose-length product‏‎ (2 revisions)
387. Security‏‎ (2 revisions)
388. Incident‏‎ (2 revisions)
389. Intermediate level waste‏‎ (2 revisions)
390. Stenosis‏‎ (2 revisions)
391. Equieffective dose‏‎ (2 revisions)
392. Local DRL‏‎ (2 revisions)
393. Expanded and aligned radiation field‏‎ (2 revisions)
394. Tolerability‏‎ (2 revisions)
395. Medical exposure‏‎ (2 revisions)
396. Naturally occurring radioactive material‏‎ (2 revisions)
397. Adventitious‏‎ (2 revisions)
398. Working level month‏‎ (2 revisions)
399. Habitual nose breather‏‎ (2 revisions)
400. Hypertrophic cardiomyopathy‏‎ (2 revisions)
401. Background dose (rate)‏‎ (2 revisions)
402. Radiosensitivity, cellular‏‎ (2 revisions)
403. Containment‏‎ (2 revisions)
404. Detriment‏‎ (2 revisions)
405. Dose-rate effect‏‎ (2 revisions)
406. Inclusiveness‏‎ (2 revisions)
407. Source-related‏‎ (2 revisions)
408. Internal conversion electron‏‎ (2 revisions)
409. Electron-capture decay‏‎ (2 revisions)
410. LD 50/30‏‎ (2 revisions)
411. Telangiectasia‏‎ (2 revisions)
412. Member of the public‏‎ (2 revisions)
413. Fluoroscopically or computed tomography guided interventions‏‎ (2 revisions)
414. Unattached fraction‏‎ (2 revisions)
415. Necrosis‏‎ (2 revisions)
416. Patient entrance reference point‏‎ (2 revisions)
417. Hypoplasia‏‎ (2 revisions)
418. Backscatter detection system‏‎ (2 revisions)
419. Potential recoverability correction factor‏‎ (2 revisions)
420. Bradycardia‏‎ (2 revisions)
421. Protective action guide‏‎ (2 revisions)
422. Radiation worker‏‎ (2 revisions)
423. Reference air kerma‏‎ (2 revisions)
424. Decay constant‏‎ (2 revisions)
425. Self-help protection‏‎ (2 revisions)
426. Individual-related‏‎ (2 revisions)
427. Dose of record Hp (10)‏‎ (2 revisions)
428. Electrophysiology‏‎ (2 revisions)
429. Storage‏‎ (2 revisions)
430. Track structure‏‎ (2 revisions)
431. Mendelian diseases‏‎ (2 revisions)
432. Accreditation‏‎ (2 revisions)
433. Neurological syndrome‏‎ (2 revisions)
434. Genomic integrity‏‎ (2 revisions)
435. Occupational exposure‏‎ (2 revisions)
436. Hazard‏‎ (2 revisions)
437. Peak skin dose‏‎ (2 revisions)
438. Bragg peak‏‎ (2 revisions)
439. Radioactive dispersion device‏‎ (2 revisions)
440. Radon: Units of Measure‏‎ (2 revisions)
441. Coronary heart disease‏‎ (2 revisions)
442. Decommissioning‏‎ (2 revisions)
443. ICRP Task Groups on Radiological Protection in Healthcare‏‎ (2 revisions)
444. Dose-threshold‏‎ (2 revisions)
445. Individual decontamination‏‎ (2 revisions)
446. Subcutaneous tissue‏‎ (2 revisions)
447. Low dose rate‏‎ (2 revisions)
448. Transfer compartment‏‎ (2 revisions)
449. Mitigation‏‎ (2 revisions)
450. Fractional absorption in the gastrointestinal tract‏‎ (2 revisions)
451. Action Level‏‎ (2 revisions)
452. Upper reference levels‏‎ (2 revisions)
453. Neurovascular syndrome‏‎ (2 revisions)
454. Health Surveillance‏‎ (2 revisions)
455. Pelagic‏‎ (2 revisions)
456. Basal cell‏‎ (2 revisions)
457. Practical radiological protection culture‏‎ (2 revisions)
458. Branching fraction‏‎ (2 revisions)
459. Chronic exposure‏‎ (2 revisions)
460. Radioactive source‏‎ (2 revisions)
461. Colony‏‎ (2 revisions)
462. Cosmic Radiation in Aviation‏‎ (2 revisions)
463. Reference biokinetic model‏‎ (2 revisions)
464. Decontamination‏‎ (2 revisions)
465. Relocation‏‎ (2 revisions)
466. Diastasis‏‎ (2 revisions)
467. Risk coefficient‏‎ (2 revisions)
468. Individual monitoring‏‎ (2 revisions)
469. Dose per unit intake coefficient‏‎ (2 revisions)
470. Source term‏‎ (2 revisions)
471. Emergency‏‎ (2 revisions)
472. Latent time/period or latency interval‏‎ (2 revisions)
473. Low level waste‏‎ (2 revisions)
474. Exposure, external or internal‏‎ (2 revisions)
475. Graft vs host disease‏‎ (2 revisions)
476. Air-kerma, incident‏‎ (2 revisions)
477. Heliosphere‏‎ (2 revisions)
478. Qualified expert‏‎ (2 revisions)
479. Class SR-0 gases‏‎ (2 revisions)
480. Radioactive substance‏‎ (2 revisions)
481. Reference individual‏‎ (2 revisions)
482. Decontamination factor‏‎ (2 revisions)
483. Remedial action‏‎ (2 revisions)
484. ICRPædia Guide to Dose Coefficients‏‎ (2 revisions)
485. Dose rate‏‎ (2 revisions)
486. Intervention Level‏‎ (2 revisions)
487. Emergency exposure situation‏‎ (2 revisions)
488. Substantial radiation dose level‏‎ (2 revisions)
489. Erythropoietin‏‎ (2 revisions)
490. Exposure (in the context of inhalation)‏‎ (2 revisions)
491. Transfer rate‏‎ (2 revisions)
492. Multi-detector computed tomography‏‎ (2 revisions)
493. Fractionation and dose delivery patterns‏‎ (2 revisions)
494. Percutaneous coronary intervention‏‎ (2 revisions)
495. Prevailing circumstances‏‎ (2 revisions)
496. Broad beam therapy irradiation technique‏‎ (2 revisions)
497. Class SR-1 gases‏‎ (2 revisions)
498. Committed effective dose‏‎ (2 revisions)
499. Radon Recommendations for Authorities‏‎ (2 revisions)
500. Cost-benefit analysis‏‎ (2 revisions)

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)